Katarzyna W. G.
- Country
- Poland
- Department
- NZOZ Dermedic Iwona Zdybska
Research Overview
- Long-Term Safety Evaluation of Oral Povorcitinib in Patients with Hidradenitis Suppurativa, Prurigo Nodularis, or Vitiligo: A Phase 3b Rollover Study
- Efficacy and Safety Evaluation of Ruxolitinib Cream in Pediatric Patients Aged 6 to <12 Years with Nonsegmental Vitiligo: A Phase 3 Randomized, Double-Blind Study
Data & Insights
Has run more than one trial at 27 of 163 partner sites.
Specializations
Dermatological Research
The investigator specializes in treating chronic spontaneous urticaria, a challenging autoimmune skin condition characterized by recurring hives and intense itching.
- Urticaria Management
- Autoimmune Skin Disorders
- Clinical Immunology
Primary focus includes evaluating innovative therapeutic approaches for patients with treatment-resistant urticaria conditions.
Immunological Studies
Expertise centers on investigating novel biological therapies targeting specific immune pathways involved in chronic urticaria development and progression.
- Immune Response Modulation
- Biological Therapeutics
- Treatment Resistance
Active involvement in advancing therapeutic options for patients with inadequate response to conventional treatments.
Clinical Assessment
Specializes in evaluating treatment efficacy through systematic clinical assessment methodologies, particularly focusing on urticaria activity scoring systems.
- Disease Activity Monitoring
- Treatment Response Assessment
- Clinical Outcomes Measurement
Implements standardized evaluation methods to track therapeutic effectiveness in chronic urticaria patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.